fda warning letters compounded semaglutide october 2025 warns consumers not to use counterfeit Ozempic (semaglutide) found in U.S. drug supply chain Congress Introduces SAFE Drugs Act

Gag Clause Prohibition Compliance Attestation as Mandated by the Consolidated Appropriations Act As we approach the December deadline for the Consolidated Appropriations Acts Gag Clause Prohibition Compliance Attestation (GCPCA) , carriers are beginning to provide related guidance

Weight loss is a potential benefit of Ozempic

Additionally, SGLT2i can lower HbA1c levels by 0.5-1.0% and support weight loss ( Studies have indicated that increased expression of the sodium-hydrogen exchanger isoform 1 (NHE-1) is linked to heart failure and may contribute to the development of hypertrophy and cardiac injury during ischemia and reperfusion ( Of note, long-term use of SGLT2i may lead to a reduction in glycosuric efficacy, without a corresponding decline in cardiovascular benefits

Conclusion: Semaglutide stands at the forefront of innovative pharmaceutical advancements

Hiramatsu T, Ozeki A, Ishikawa H, Furuta S

\No Worsening of Insulin Sensitivity: Does not appear to negatively impact blood sugar control, even with increased growth hormone activity